2016
DOI: 10.18087/rhj.2016.6.2232
|View full text |Cite
|
Sign up to set email alerts
|

Peculiarities of the correction of hormonal and metabolic risk factors in patients with ischemic heart disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The components of seaweeds, such as fucoxanthin, which is found in brown seaweeds, have been shown to have anticoagulant, platelet aggregation-inhibiting and anti-inflammatory properties (Liu et al, 2013). Patients with atherogenic dyslipidemia and ischemic heart disease have shown benefits from fucoxanthin, a substance present in seaweed oils, in terms of preventing atherosclerosis (Ionov and Basova, 2003;Khan et al, 2006) by downregulating LDL receptors and promoting expression of sterol regulatory element binding proteins (Airanthi et al, 2011;Beppu et al, 2012).…”
Section: Cardiovascular Diseasesmentioning
confidence: 99%
“…The components of seaweeds, such as fucoxanthin, which is found in brown seaweeds, have been shown to have anticoagulant, platelet aggregation-inhibiting and anti-inflammatory properties (Liu et al, 2013). Patients with atherogenic dyslipidemia and ischemic heart disease have shown benefits from fucoxanthin, a substance present in seaweed oils, in terms of preventing atherosclerosis (Ionov and Basova, 2003;Khan et al, 2006) by downregulating LDL receptors and promoting expression of sterol regulatory element binding proteins (Airanthi et al, 2011;Beppu et al, 2012).…”
Section: Cardiovascular Diseasesmentioning
confidence: 99%